Which drug should NOT be used in treating subacute thyroiditis?

Study for the NBME Form 13 Test with our comprehensive quiz collection, featuring flashcards and multiple-choice questions to ensure your readiness. Enhance your knowledge with detailed explanations for each question.

Multiple Choice

Which drug should NOT be used in treating subacute thyroiditis?

Explanation:
Subacute thyroiditis presents with a painful, tender thyroid after a viral illness and causes a thyrotoxic phase because the inflamed thyroid releases stored hormone, not because it is overproducing it. The goal of treatment is to reduce inflammation and relieve symptoms, not to suppress hormone synthesis. NSAIDs are used to treat the inflammatory pain, and prednisone is added if the inflammation is more severe. Beta-blockers help control rapid heart rate, tremor, and anxiety during the thyrotoxic phase. In contrast, a drug that blocks thyroid hormone synthesis would not address the underlying release of preformed hormone and is not indicated in this setting; it won’t hasten recovery and can complicate the course. So this condition is managed with anti-inflammatories and symptomatic support rather than antithyroid drugs.

Subacute thyroiditis presents with a painful, tender thyroid after a viral illness and causes a thyrotoxic phase because the inflamed thyroid releases stored hormone, not because it is overproducing it. The goal of treatment is to reduce inflammation and relieve symptoms, not to suppress hormone synthesis. NSAIDs are used to treat the inflammatory pain, and prednisone is added if the inflammation is more severe. Beta-blockers help control rapid heart rate, tremor, and anxiety during the thyrotoxic phase. In contrast, a drug that blocks thyroid hormone synthesis would not address the underlying release of preformed hormone and is not indicated in this setting; it won’t hasten recovery and can complicate the course. So this condition is managed with anti-inflammatories and symptomatic support rather than antithyroid drugs.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy